Affiliation:
1. Department of Otolaryngology‐Head and Neck Surgery Massachusetts Eye and Ear Boston Massachusetts U.S.A.
2. Department of Pediatric Pulmonology and Sleep Medicine Massachusetts General Hospital Boston Massachusetts U.S.A.
Abstract
IntroductionHypoglossal nerve stimulation (HGNS) is an effective therapy for carefully selected pediatric patients with Down syndrome (DS) and obstructive sleep apnea (OSA), but optimization of device settings has been focused on stimulation settings. The potential benefits of sensing lead setting optimization have not been investigated. We describe a series of three cases of HGNS in children with DS where optimization of both the stimulation lead and sensing lead settings, as well as utilization of drug‐induced sleep endoscopy (DISE), when indicated, was more effective than stimulation lead optimization alone.MethodsUsing our novel titration algorithm, among the three identified pediatric patients with DS in whom HGNS initially failed to reduce the apnea‐hypopnea index (AHI), two patients in whom sleep studies were characterized as hypopnea‐dominant were assigned to advanced titration (optimization of stimulation settings and sensing lead settings). The third patient, with an obstructive apnea‐dominant sleep study, was referred for interrogated DISE. Advanced titration included adjustment of both stimulation settings and sensing lead settings.ResultsApplication of the advanced titration algorithm, tailored to obstructive apnea‐ versus hypopnea‐dominant sleep patterns, resulted in approximately 50% or greater reduction in AHI in all three patients. “Normal to mild OSA” AHI (AHI <5) was achieved in two patients.ConclusionsA novel diagnostic and therapeutic titration algorithm for the Inspire HGNS system significantly reduced AHI in three pediatric patients with DS and OSA who had failed to respond to the standard device titration that focused solely on stimulation settings.Level of Evidence4 Laryngoscope, 2024